These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33121968)

  • 1. Early Outcomes of Multivisceral Transplant Using Hepatitis C-Positive Donors.
    McMaster WG; Rahaman ZM; Shipe ME; Quintana EN; Sandhaus EM; Smith SS; Crockett JE; Forbes RC; Schlendorf KH; Shah AS
    Ann Thorac Surg; 2021 Aug; 112(2):511-518. PubMed ID: 33121968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provider Attitudes toward the Use of Hepatitis C Virus-Positive Organs in Kidney Transplantation.
    Couri T; Katz J; Stoeckle K; Nugooru A; Yeh H; Chung R; Paul S
    Am J Nephrol; 2019; 50(3):168-176. PubMed ID: 31390615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
    Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
    Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
    Cannon RM; Locke JE; Orandi BJ; Anderson DJ; Davis EG; Mackelaite L; Dave H; Eng M; Jones CM
    Transplantation; 2020 Jun; 104(6):1215-1228. PubMed ID: 31517783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of Renal Transplant From Deceased Anti-hepatitis C Virus Donors, Poland 1998-2012.
    Pliszczyński J; Jasztal K; Jóźwik A; Kosieradzki M; Danielewicz R; Małkowski P; Czerwiński J
    Transplant Proc; 2018; 50(6):1691-1696. PubMed ID: 30056883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
    Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
    Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of using hepatitis c virus nucleic acid test-positive donor hearts on heart transplant waitlist time and transplant rate.
    Gernhofer YK; Brambatti M; Greenberg BH; Adler E; Aslam S; Pretorius V
    J Heart Lung Transplant; 2019 Nov; 38(11):1178-1188. PubMed ID: 31492607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.
    Pereira BJ; Wright TL; Schmid CH; Levey AS
    Lancet; 1995 Feb; 345(8948):484-7. PubMed ID: 7532254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.
    Bethea ED; Gaj K; Gustafson JL; Axtell A; Lebeis T; Schoenike M; Turvey K; Coglianese E; Thomas S; Newton-Cheh C; Ibrahim N; Carlson W; Ho JE; Shah R; Nayor M; Gift T; Shao S; Dugal A; Markmann J; Elias N; Yeh H; Andersson K; Pratt D; Bhan I; Safa K; Fishman J; Kotton C; Myoung P; Villavicencio MA; D'Alessandro D; Chung RT; Lewis GD
    Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):771-780. PubMed ID: 31353243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C viraemic organs in solid organ transplantation.
    Weinfurtner K; Reddy KR
    J Hepatol; 2021 Mar; 74(3):716-733. PubMed ID: 33212088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C-positive donor to negative recipient kidney transplantation: A real-world experience.
    Jandovitz N; Nair V; Grodstein E; Molmenti E; Fahmy A; Abate M; Bhaskaran M; Teperman L
    Transpl Infect Dis; 2021 Jun; 23(3):e13540. PubMed ID: 33259125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding Heart Transplant in the Era of Direct-Acting Antiviral Therapy for Hepatitis C.
    Schlendorf KH; Zalawadiya S; Shah AS; Perri R; Wigger M; Brinkley DM; Danter MR; Menachem JN; Punnoose LR; Balsara K; Sacks SB; Ooi H; Awad JA; Sandhaus E; Schwartz C; O'Dell H; Carver AB; Edmonds CL; Ruzevich-Scholl S; Lindenfeld J
    JAMA Cardiol; 2020 Feb; 5(2):167-174. PubMed ID: 31851352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OPTN/SRTR 2018 Annual Data Report: Hepatitis C.
    Wang JH; Gustafson SK; Skeans MA; Lake JR; Kim WR; Kasiske BL; Israni AK; Hart A
    Am J Transplant; 2020 Jan; 20 Suppl s1():542-568. PubMed ID: 31898411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
    Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
    Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing multiorgan heart transplantation with hepatitis C virus donors in the current-era.
    Madan S; Patel SR; Vlismas P; Hemmige V; Saeed O; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2021 Nov; 40(11):1382-1386. PubMed ID: 34176726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor.
    Stepanova M; Sayiner M; de Avila L; Younoszai Z; Racila A; Younossi ZM
    BMC Gastroenterol; 2016 Nov; 16(1):137. PubMed ID: 27846801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
    Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
    N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.